Copy number variants (CNVs): a powerful tool for iPSC-based modelling of ASD.
Danijela Drakulic, Srdjan Djurovic, Yasir Ahmed Syed and 11 others
PMID 32487215WHAT IT FOUND
Some autism cases carry copy number variants, and patient stem-cell neurons can model some biological changes.
This review reports no clinical outcomes or therapy changes.
Key findings
01An estimated 5–10% of all autism spectrum disorder cases carry copy number variants.
02At least 90 pathogenic copy number variants have been reported for autism spectrum disorder.
03Patient stem-cell-derived cultures can capture some altered neuronal activity, but they do not recapitulate higher-order brain organisation or circuitry.
STILL TO COME
How it was doneWhat they found
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
This is a review, not a new patient study, so it does not test any intervention or outcome. The cited stem-cell studies are laboratory models, not clinical trials of therapy. Stem-cell-derived neurons are immature and may not reflect adult brain function. Reprogramming can create new copy number variants, which can confound patient cell studies. Cell cultures do not recapitulate higher-order brain organisation or circuitry. The paper does not show that genetic or cellular findings can guide patient care.
Declared interests
The supplied text states that the European Cooperation in Science and Technology funded the work. It does not list author financial conflicts.
The easy way to misread this
Do not read this as evidence that any autism therapy works or that stem-cell findings can guide patient care. The paper reviews laboratory models and reports no clinical outcomes.